Logo
  • About
  • Contact
  • (888) 441-8033

Ehave, Inc. PsyTech Subsidiary Hosts Live Investor Conference & Webinar April 22: Mainstreaming Psychedelics: Are We Ready Yet?

Miami, Florida – April 22, 2020 - Ehave, Inc., (OTC Pink: EHVVF) (the “Company”) and its subsidiary PsyTech announced an upcoming Psychedelic Industry Virtual lnvestor Conference and Webinar. The virtual investor webinar is open to individual investors, institutional investors...

View full release

Salarius Pharmaceuticals: Numerous Upcoming Clinical Milestones with Limited COVID-19 Disruption to Date

Salarius Pharmaceuticals advanced dose escalation in Ewing Sarcoma trial with early stage clinical readouts in 2020. The company reached the sixth level dosing cohort in its phase 1/2 study of Seclidemstat in Ewing sarcoma upon the Safety Committee Review. Seclidemstat has re...

View full release

New Yorkers say: Don't re-open the economy before June- CUNY SPH COVID-19 Survey Week 6

Nearly half (49%) of New York City residents believe we should wait until after June 1st to reopen all non-essential businesses, while 19% said openings should take place between May 16-31. These findings are part of the sixth weekly city and statewide tracking survey from the...

View full release

NFL Alumni Association and American Addiction Centers Team Up to Give Former Players Access to Addiction Treatment Amid COVID-19

At a time when many people are struggling to mentally cope with COVID-19 and turning to substances to get by, the NFL Alumni Association (NFLA) has partnered with American Addiction Centers (AAC) to provide a lifeline to former players and their families. Effective immediately...

View full release

Inflammatix Appoints João Fonseca, Ph.D., as Chief Technology Officer

Burlingame, Calif., April 16, 2020 --- Inflammatix, a pioneering molecular diagnostics company delivering precision medicine at the point of care, today announced the appointment of João Fonseca, Ph.D., as Chief Technology Officer. Dr. Fonseca will oversee Inflammatix’s molecu...

View full release

Analytical Validation of Cofactor Genomics’ Immune Profiling Assay Published in Journal of Molecular Diagnostics

SAN FRANCISCO, Calif. – April 16, 2020 – Today, Cofactor Genomics announced the peer-reviewed publication of an analytical validation study demonstrating the performance of its novel RNA-based immune profiling assay, ImmunoPrism®, in the April 2020 issue of the Journal of Mole...

View full release

American Mattress Alliance Refutes Petitioners’ Exaggerated Data

NEW YORK CITY—The American Mattress Alliance (AMA) released a new statement today regarding the antidumping petition filed on March 31, 2020 against Vietnam, Thailand, Serbia, Turkey, Cambodia, Malaysia, and Indonesia. Petitioners have used statistics that cite a 52,000 percen...

View full release

US Equity Advantage Remains Fully Staffed to Support Record Number of Pre-Pandemic Enrollments

ORLANDO, Fla. (April 14, 2020) – February enrollments in US Equity Advantage’s (USEA) biweekly F&I service set a single-month record for the 17-year-old company following its expansion to all 50 states. In anticipation, USEA had expanded its dealer services team and beefed up ...

View full release

NFL Alumni Teams Up With Strive Orthopedics

NFL Alumni (NFLA) has teamed up with Strive Orthopedics (Strive) to provide the next level of orthopedic care to NFLA members. Strive is a total care platform redefining the delivery of musculoskeletal care by empowering patients through mobile software and wearable technology...

View full release

CUNY New York City COVID-19 Survey Week 5

The latest CUNY coronavirus tracking survey found that a majority of (77%) of New Yorkers who typically attend holiday services found alternative ways to practice their faith during Easter and Passover week. Among the observant, 43% reported watching or listening to services o...

View full release
  • « First
  • ‹ Prev
  • …
  • 179
  • 180
  • 181
  • 182
  • 183
  • 184
  • 185
  • 186
  • 187
  • …
  • Next ›
  • Last »
©2025 Reportable, Inc.
Terms and Conditions | Privacy Policy